AST-120
- Generic Name
- AST-120
AST-120 in Hemodialysis Patients With Uremic Pruritus
- First Posted Date
- 2020-11-20
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Conmed Pharmaceutical & Bio-Medical Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT04639674
- Locations
- 🇨🇳
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
🇨🇳Taichung Veterans General Hospital, Taichung, Taiwan
🇨🇳Taipei Tzu Chi Hospital, New Taipei City, Taiwan
Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects
- Conditions
- Type 2 Diabetes MellitusHealthy Subjects
- Interventions
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 6
- Registration Number
- NCT03802487
- Locations
- 🇬🇧
Investigational site number 8260001, Nottingham, United Kingdom
Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2015-03-13
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 70
- Registration Number
- NCT01863888
- Locations
- 🇧🇪
Investigational Site Number 056003, Sijsele-Damme, Belgium
🇧🇪Investigational Site Number 056002, Overpelt, Belgium
🇩🇪Investigational Site Number 276-002, Ulm, Germany
Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.
- First Posted Date
- 2012-09-07
- Last Posted Date
- 2013-08-06
- Lead Sponsor
- Chang Gung Memorial Hospital
- Target Recruit Count
- 51
- Registration Number
- NCT01681303
- Locations
- 🇨🇳
Department of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan
Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Tungs' Taichung Metroharbour Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01458652
- Locations
- 🇨🇳
PS Lim, Taichung, Taiwan
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
- First Posted Date
- 2010-07-07
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Ewha Womans University
- Target Recruit Count
- 30
- Registration Number
- NCT01157260
- Locations
- 🇰🇷
Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of
AST-120 Used to Treat Mild Hepatic Encephalopathy
- First Posted Date
- 2009-03-24
- Last Posted Date
- 2014-06-18
- Lead Sponsor
- Ocera Therapeutics
- Target Recruit Count
- 148
- Registration Number
- NCT00867698
- Locations
- 🇺🇸
Beth Israel Deaconnes Medical Center, Harvard Medical School, Boston, Massachusetts, United States
🇺🇸Albert Einstein Medical Center, Division of Hepatology, Philadelphia, Pennsylvania, United States
🇺🇸UT Southwestern Medical Center, Dallas, Texas, United States
Kremezin Study Against Renal Disease Progression in Korea
- First Posted Date
- 2009-03-12
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 578
- Registration Number
- NCT00860431
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- Interventions
- Drug: Celphere CP-305
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2014-06-18
- Lead Sponsor
- Ocera Therapeutics
- Target Recruit Count
- 4
- Registration Number
- NCT00587275
- Locations
- 🇺🇸
Southern Arizona VA Health Care System and University of Arizona Health Sciences Center, Tucson, Arizona, United States
Safety and Efficacy of AST-120 in the Treatment of Pouchitis
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2014-06-18
- Lead Sponsor
- Ocera Therapeutics
- Target Recruit Count
- 19
- Registration Number
- NCT00583076
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.